Company intelligence / Profile preview

Arterium

Kyiv, Ukraine
Ownership
Private
Employees
~3000
Development stage
Other
01

Overview

Arterium is one of the leading Ukrainian pharmaceutical companies, producing over 150 registered drugs for human health and 17 veterinary products, including generics and patented originals; operates two GMP-certified production plants, with significant local and international distribution

Therapeutic areas
RheumatologyInfectious DiseasesPulmonologyDermatologyCardiovascularOtherNeurologyWomen's Health
Modalities
Small moleculeBiologicHerbal medicines
Industry
Biotech
02

Drug pipeline

1 asset

Osmolife

Unknown

Beyond the preview

Go deeper on Arterium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call